These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22127297)

  • 1. Idrabiotaparinux treatment for venous thromboembolism.
    Eikelboom JW; Weitz JI
    Lancet; 2012 Jan; 379(9811):96-8. PubMed ID: 22127297
    [No Abstract]   [Full Text] [Related]  

  • 2. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
    Büller HR; Gallus AS; Pillion G; Prins MH; Raskob GE;
    Lancet; 2012 Jan; 379(9811):123-9. PubMed ID: 22130488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
    Buller HR; Halperin J; Hankey GJ; Pillion G; Prins MH; Raskob GE
    J Thromb Haemost; 2014 Jun; 12(6):824-30. PubMed ID: 24597472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) Trial.
    Liu X; Johnson M; Mardekian J; Phatak H; Thompson J; Cohen AT
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26627879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversibility of the anti-FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion.
    Paty I; Trellu M; Destors JM; Cortez P; Boëlle E; Sanderink G
    J Thromb Haemost; 2010 Apr; 8(4):722-9. PubMed ID: 20088937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Anticoagulant Therapy in Pediatric Patients Hospitalized With Pulmonary Embolism or Deep Vein Thrombosis: A Retrospective Cohort Study.
    Singh RR; Gupte-Singh KR; Wilson JP; Moffett BS
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):260-4. PubMed ID: 26311289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis.
    Equinox Investigators
    J Thromb Haemost; 2011 Jan; 9(1):92-9. PubMed ID: 20946157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory therapy of patients with free-floating proximal deep vein thrombosis is safe.
    Patel RK; Ramasamy K; Goss D; Deane C; Bonner L; Arya R
    Thromb Haemost; 2005 Dec; 94(6):1343-4. PubMed ID: 16411421
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombophilia and the Risk of Recurrent Venous Thromboembolism.
    Rhinehart ZJ; Rivera-Lebron B; George MP
    JAMA; 2015 Nov; 314(18):1975-6. PubMed ID: 26547471
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
    Agnelli G; Buller HR; Cohen A; Gallus AS; Lee TC; Pak R; Raskob GE; Weitz JI; Yamabe T
    J Thromb Haemost; 2015 Dec; 13(12):2187-91. PubMed ID: 26407753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) study.
    Lassen MR; Dahl O; Mismetti P; Zielske D; Turpie AG
    J Am Coll Cardiol; 2008 Apr; 51(15):1498-504. PubMed ID: 18402906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home treatment of deep venous thrombosis in the era of new oral anticoagulants.
    Stein PD; Matta F; Hughes PG; Ghiardi M; Marsh JH; Khwarg J; Brandon MS; Fowkes HA; Kazan V; Wiepking M; Keyes DC; Kakish EJ; Hughes MJ
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):729-32. PubMed ID: 26239315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilia and the Risk of Recurrent Venous Thromboembolism--Reply.
    Couturaud F; Meyer G; Mottier D
    JAMA; 2015 Nov; 314(18):1976. PubMed ID: 26547473
    [No Abstract]   [Full Text] [Related]  

  • 16. [What happens after discontinuation of anticoagulation after unprovoked pulmonary embolism?].
    Praxis (Bern 1994); 2015 Sep; 104(19):1043-4. PubMed ID: 26373914
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation therapy: Benefits of extended oral anticoagulation after first episode of pulmonary embolism.
    Huynh K
    Nat Rev Cardiol; 2015 Sep; 12(9):499. PubMed ID: 26216623
    [No Abstract]   [Full Text] [Related]  

  • 18. Outpatient management of pulmonary embolism.
    Howard L; Salooja N
    Lancet; 2011 Jul; 378(9785):5-6. PubMed ID: 21703675
    [No Abstract]   [Full Text] [Related]  

  • 19. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of heparin/warfarin and enoxaparin thromboprophylaxis in spinal cord injury: the Sheffield experience.
    Thumbikat P; Poonnoose PM; Balasubrahmaniam P; Ravichandran G; McClelland MR
    Spinal Cord; 2002 Aug; 40(8):416-20. PubMed ID: 12124668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.